172 related articles for article (PubMed ID: 17701831)
1. Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
Xenobiotica; 2007 Aug; 37(8):818-31. PubMed ID: 17701831
[TBL] [Abstract][Full Text] [Related]
2. Functional involvement of the organic cation transporter 2 (rOct2) in the renal uptake of organic cations in rats.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
J Int Med Res; 2008; 36(1):123-36. PubMed ID: 18230276
[TBL] [Abstract][Full Text] [Related]
3. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008
[TBL] [Abstract][Full Text] [Related]
5. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K
Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional expression of a human liver organic cation transporter.
Zhang L; Dresser MJ; Gray AT; Yost SC; Terashita S; Giacomini KM
Mol Pharmacol; 1997 Jun; 51(6):913-21. PubMed ID: 9187257
[TBL] [Abstract][Full Text] [Related]
7. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity.
Tu M; Sun S; Wang K; Peng X; Wang R; Li L; Zeng S; Zhou H; Jiang H
Toxicology; 2013 Sep; 311(3):225-30. PubMed ID: 23831208
[TBL] [Abstract][Full Text] [Related]
8. High affinity of 4-(4-(dimethylamino)styryl)-N-methylpyridinium transport for assessing organic cation drugs in hepatocellular carcinoma cells.
Jinakote M; Ontawong A; Soodvilai S; Pimta J; Pasachan T; Chatsudthipong V; Srimaroeng C
Fundam Clin Pharmacol; 2020 Jun; 34(3):365-379. PubMed ID: 31883148
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Zhang L; Schaner ME; Giacomini KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
[TBL] [Abstract][Full Text] [Related]
10. Comparison of "type I" and "type II" organic cation transport by organic cation transporters and organic anion-transporting polypeptides.
van Montfoort JE; Müller M; Groothuis GM; Meijer DK; Koepsell H; Meier PJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):110-5. PubMed ID: 11408531
[TBL] [Abstract][Full Text] [Related]
11. Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes.
Badolo L; Trancart MM; Gustavsson L; Chesné C
Chem Biol Interact; 2011 Apr; 190(2-3):165-70. PubMed ID: 21356203
[TBL] [Abstract][Full Text] [Related]
12. Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1-3 in vitro and implications for drug-drug interactions.
Umehara KI; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Xenobiotica; 2008 Sep; 38(9):1203-18. PubMed ID: 18686197
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
14. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biopharm Drug Dispos; 2009 Nov; 30(8):476-84. PubMed ID: 19768675
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatic uptake transporters by flavonoids.
Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
[TBL] [Abstract][Full Text] [Related]
16. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1.
Busch AE; Quester S; Ulzheimer JC; Waldegger S; Gorboulev V; Arndt P; Lang F; Koepsell H
J Biol Chem; 1996 Dec; 271(51):32599-604. PubMed ID: 8955087
[TBL] [Abstract][Full Text] [Related]
17. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
Urakami Y; Okuda M; Masuda S; Saito H; Inui KI
J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712
[TBL] [Abstract][Full Text] [Related]
18. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
[TBL] [Abstract][Full Text] [Related]
19. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
20. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1.
Li L; Song F; Tu M; Wang K; Zhao L; Wu X; Zhou H; Xia Z; Jiang H
Int J Pharm; 2014 Apr; 465(1-2):5-10. PubMed ID: 24530383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
